Harold Doll JR. in Tallahassee, Florida

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Oral Roberts University School Of Medicine
Graduation Year: 1985
The Primary Medical Specialty for Harold Doll JR. is listed as: Nephrology
Approximate Years of Experience: 39
PAC (PECOS ID)#: 0547342834
NPI #: 1093717654
NPI Created On: 08/12/2005
NPI Last Updated Listed as: 02/05/2020
Primary Taxonomy Code: 207RN0300X
License Number:
ME48984
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Hemodialysis procedure with one physician evaluation
2. Dialysis services (4 or more physician visits per month), patient 20 years of age and older
3. Dialysis services (2-3 physician visits per month), patient 20 years of age and older
4. Dialysis services (1 physician visit per month), patient 20 years of age and older
5. Dialysis services, per day (less than full month service), patient 20 years of age or older
6. New patient office or other outpatient visit, typically 45 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Established patient office or other outpatient, visit typically 40 minutes
10. Initial hospital inpatient care, typically 50 minutes per day
11. Initial hospital inpatient care, typically 70 minutes per day
12. Subsequent hospital inpatient care, typically 15 minutes per day
13. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.